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2Abstract
The regulation and control of plasma membrane Ca2+ fluxes is critical for the
initiation and maintenance of a variety of signal transduction cascades. Recently,
the study of transient receptor potential channels (TRPs) has suggested that these
proteins have an important role to play in mediating capacitative calcium entry. In
this study, we have isolated a cDNA from human brain that encodes a novel
transient receptor potential channel termed human TRP7 (hTRP7). hTRP7 is a
member of the short TRP channel family and is 98% homologous to mouse TRP7
(mTRP7). At the mRNA level hTRP7 was widely expressed in tissues of the
central nervous system, as well as some peripheral tissues such as pituitary gland
and kidney. However, in contrast to mTRP7, which is highly expressed in heart
and lung, hTRP7 was undetectable in these tissues. For functional analysis, we
heterologously expressed hTRP7 cDNA in an human embryonic kidney cell line.
In comparison with untransfected cells depletion of intracellular calcium stores in
hTRP7 expressing cells, using either carbachol or thapsigargin, produced a
marked increase in the subsequent level of Ca2+ influx . This increased Ca2+
entry was blocked by inhibitors of capacitative calcium entry such as La3+ and
Gd3+. Furthermore, transient transfection of an hTRP7 anti-sense expression
construct into cells expressing hTRP7, eliminated the augmented store operated
Ca2+ entry. Our findings suggest that hTRP7 is a store-operated calcium channel,
a finding in stark contrast to the mouse orthologue, mTRP7, which is reported to
3enhance Ca2+ influx independently of store depletion, and suggests that human
and mouse TRP7 channels may fulfil different physiological roles.
Introduction
Numerous G-protein-coupled receptors signal through the phospholipase C
pathway to liberate intracellular Ca2+ stores and elicit the activation of a variety
of cellular signal transduction pathways. Intrinsic to the integrity of this system is
the process of refilling of these Ca2+ stores which requires a regulated Ca2+
influx across the plasma membrane. Two broad mechanisms appear to be
responsible for activating this Ca2+ influx and consequent store refilling.  In a
number of systems, store depletion itself seems to activate refilling. This can be
experimentally demonstrated by passively depleting Ca2+ stores with Ca2+
ATPase inhibitors such as thapsigargin1;2. As no obvious chemical messenger is
involved this mechanism it has been dubbed capacitative Ca2+ entry (CCE) or
store operated Ca2+ (SOC) entry. The second key mechanism operates
independently of Ca2+ release from intracellular stores, whereby downstream
products of the phospholipase Cβ cascade directly activate Ca2+ influx3-7.
The initial leads in the hunt to identify the molecular basis of the store refilling
pathway were provided by study of phototransduction in Drosophila
melanogaster. In photoreceptor cells three related genes have been isolated whose
products have been reported to function as calcium permeable channels: the
transient receptor potential (trp) gene8;9, the transient receptor potential-like (trpl)
4gene10 and the transient receptor potential gamma (trpγ) gene11. Expression of trp
in a baculovirus system produced currents when intracellular Ca2+ stores were
depleted with thapsigargin12;13, a result indicative of a role as a store-operated
channel mediating CCE. In contrast however, heterologous expression of trpl and
trpγ resulted in currents that were constitutively active irrespective of Ca2+ store
status and therefore were not classified as store operated channels10;14;15.
Thus far, seven short mammalian cDNA homologues of drosophila TRP channels
have been identified, termed TRP1-716-19. A common characteristic of these
channels is that they are Ca2+-permeable, non-selective cation channels. Analysis
of the channel activation properties of some mammalian TRP channels has lead to
different  results being obtained dependent on the expression system used.  TRP1,
however, clearly produced a current activated by Ca2+ store depletion both in
recombinant 20 and native systems.  Less is known about the TRP2 gene product;
although it has also been reported to have store-operated properties21, the human
orthologue of TRP2 appears to be a pseudogene22. TRP4 and 5 have been
implicated in both receptor- and store-operated channel function depending on the
cell line in which they are expressed and the source of the channel (i.e. human or
mouse)23-27.  Genetic deletion28 or anti-sense knockdown29 of native expression of
TRP4 suggests that this channel functions as store-operated channel. Lastly TRP3
and TRP6 expressed in recombinant systems, are activated by diacylglycerols
independent of the ability of this lipid to activate protein kinase C30;31. Anti-sense
knockdown of TRP6 expression in native vascular smooth muscle resulted in a
5reduction of alpha adrenergic receptor-mediated store depletion-independent
Ca2+ influx32, strongly supporting the concept that this channel is gated by a
signal upstream of store depletion. TRP7, a third member of the TRP3/6
subfamily has only been characterised from the mouse31. This work demonstrated
that mouse TRP7 expressed in HEK293 cells coded for a channel, that like TRP3
and TRP6, is gated by products of G- protein-coupled receptor signalling but
cannot be activated by depletion of Ca2+ stores with thapsigargin.
In this study, we performed homology searching against the GenBank sequence
database using the human TRP3 protein sequence23;33. This lead to the
identification of human short TRP7 (hTRP7). TaqMan real time quantitative RT-
PCR34-36 was used to investigate the mRNA distribution of hTRP7 in CNS and
peripheral tissues, and in a panel of cell lines. Expression of hTRP7 in HEK-293
cells resulted in enhanced CCE following emptying of Ca2+ stores by carbachol
or by the Ca2+ pump inhibitor thapsigargin. In addition, expression of an anti-
sense hTRP7 cDNA provided further evidence that, in contrast to its rodent
orthologue, hTRP7 functions as a store operated calcium channel. hTRP7
therefore differs from its mouse orthologue (mTRP7) not only in its mRNA
expression profile but also in its activation properties, suggesting that it should
not be functionally grouped with its closest relatives, TRP3 and TRP6.
Experimental Procedures
Identification of human TRP7 using homology searching
6Homology searching against the GenBank sequence database using the human
TRP3 protein sequence (accession number U47050) was performed using
TBLASTN237.
Cloning and epitope tagging of human TRP7
Sequence data from the ORF of human TRP7 was used to design specific primers
to amplify the complete coding sequence of the gene by polymerase chain
reaction (PCR). Primers used were sense (5'-
CCCAAGCTTATGTTGAGGAACAGCACCTTC-3') and anti-sense (5'-
CCCCTCGAGCTAAATGTCTTTGCCCTTGTTCAC-3') that contained the
restrictions sites HindIII and XhoI respectively.
PCR amplification was performed from human brain, pituitary gland and kidney
cDNA libraries using Expand polymerase (Roche Molecular biochemicals,
Mannheim, Germany). The amplified cDNA was subcloned into the mammalian
expression vector pcDNA 3.1/V5-His-Topo (Invitrogen, Groeningen, The
Netherlands). For functional studies a FLAG epitope was fused in frame to the N-
terminus of hTRP7 by subcloning the entire hTRP7 cDNA into the epitope
tagging mammalian expression vector pCMV-Tag2b (Stratagene, The
Netherlands). For anti-sense experiments, the complete coding cDNA of human
TRP7 was subcloned into pAsRed1-C1 vector (Clontech, California, USA) in
anti-sense orientation downstream of the red fluorescent protein (RFP) cDNA to
obtain pAsRed1-C1-hTRP7AS.
7Distribution analysis of hTRP7 by using TaqMan RT-PCR
TaqMan RT-PCR assays were carried out as previously described36;36;38 using
sense (5'-TGGGCATGCTGAATTCCAAA-3') and anti-sense (5'-
GCTGTCAGATTTTCAGAATTCCTCA-3') primers and the TaqMan probe 5-
TCAAGAAGACTCGCTACCAGGCTGGC-3', designed to specifically amplify
hTRP7.
Human tissues from four individuals (two men, two women, except prostate;
were provided by Dr. R. David Netherland's Brain Bank, Amsterdam) or
purchased as prepared RNA from Biochain (San Leandro, CA), Clontech (Palo
Alto, CA). All samples were anonymous and were obtained under conditions of
informed consent.
RNA from cell lines was prepared using Trizol reagent (Invitrogen) following the
manufacturer's protocol. Parallel assays on the same RNA samples were carried
out using primers and probes to the 'housekeeping' gene β-actin39.
Culture and Transfection of HEK-293 Cells
HEK-293 cells were cultured in Minimum Essential Medium with Eagle's salts,
supplemented with 10% fetal bovine serum. The hTRP7 stable cell line was
obtained by transfecting HEK-293 with the pCMV-Tag2b-hTRP7 construct using
Lipofectamine 2000 (Invitrogen), then selecting with 400 µg/ml Geneticin
(Invitrogen). TaqMan RT-PCR was used to analyse the expression of hTRP7
mRNA in the resistant clones.
8HEK-293 cells were transiently transfected using Lipofectamine 2000
(Invitrogen), according to the manufacturer's instructions. For
immunocytochemistry assays, cells on coverslips were fixed 48 h post-
transfection with 4% paraformaldehyde and then either permeabilised with 0.1%
Triton X-100 or washed with phosphate buffered saline (PBS). The anti-flag
antibody (Stratagene) was used at 1:5000 in PBS. The goat anti-mouse IgG-FITC
secondary antibody (Sigma-Aldrich, Dorset, England) was used 1:100 in PBS.
Fluorescence was viewed using a Leica laser scanning confocal microscope.
Measurements of changes in [Ca2+]i
HEK-293 cells attached to coverslips were loaded with Fura-2-AM (5 µM,
Molecular Probes) in culture medium for 30 min at 37°C in the dark. Cells were
then extensively washed with HEPES-buffered saline (HBS) containing 107 mM
NaCl, 6 mM KCl, 1.2 mM MgSO4, 2 mM CaCl2, 1.2 mM KH2PO4, 11.5 mM
glucose, 20 mM HEPES pH 7.3. For Ca2+-free HBS, CaCl2 was removed and
EGTA (0.5 mM) added. For the experiments using GdCl3 or LaCl3, KH2PO4 was
omitted from HBS. SKF-96365 was purchased from Tocris. Images were captured
using an Olympix Peltier cooled CCD camera (Perkin Elmer, USA). Regions
containing between 20-40 cells were selected and intracellular free Ca2+
concentration was evaluated by measurement of Fura-2 fluorescence. Briefly,
fluorescence was measured  using alternating excitation wavelengths of 340 and
380 nm and monitoring fluorescence emission at 510 nm. Excitation was
performed with a commercially available monochromator based microfluorimetry
9system (Olympus). Cells were imaged using a Plan X 40 (1.30 NA) oil-immersion
lens (Nikon) and analyzed using UltraView software (Perkin Elmer). Data
acquisition was typically at 3.9-s intervals. Changes in intracellular free Ca2+
concentration were expressed as the ratio of emission (510 nm) for 340nm/380nm
excitation (F340/380). Experiments were performed at room temperature. Data were
accumulated under each condition from 3 to 5 experiments.
For anti-sense experiments, RFP-positively transfected cells were identified using
an excitation wavelength of 555 nm and monitoring emission at 585 nm.
Mn2+ entry was measured using the same system as described for Ca2+
measurements. The decrease of Fura-2 fluorescence was monitored at its
isosbestic point of excitation (358 nm). Cells were bathed in 107 mM NaCl, 6
mM KCl, 1.2 mM MgSO4, 1 mM MnCl2, 11.5 mM glucose, 20 mM HEPES pH
7.3.
Results
Molecular Cloning and Sequence Analysis of hTRP7
As part of a genomics-based programme to identify novel ion channels we
identified unfinished genomic sequence (GenBank Accession number;
AC008661) with similarity to the human short TRP3 protein. Further homology
searching indicated that this human sequence was most closely related to the
recently identified mouse TRP7 gene (AF139923). The initiation codon was
missing from this original gene prediction but the subsequent appearance of
newer, genomic sequence (AC063980) allowed the identification of an additional
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exon at the 5' end of the human gene. The initiation ATG codon was split between
exons 1 and 2.
hTRP7 contained an open reading frame (ORF) of 2589 bp encoding a protein of
862 amino acids with a predicted molecular mass of 100 kDa and an isoelectric
point of 7.86 (Fig. 1A). The predicted protein sequence of this submission is
identical to a sequence subsequently deposited (AJ272034) with the exception of
a single leucine to proline amino acid change at position 111. This amino acid
change is caused by a T to C nucleotide change at base pair position 332
(numbering from the initiation codon). We validated this sequence change by
cloning hTRP7 from two additional human libraries derived from pituitary gland
and kidney. The sequence analysis performed on these two clones revealed the
presence of the same base change at position 332 (T to C) demonstrating that this
is not a cloning or PCR derived artefact.
Analysis of hTRP7 using the TMPRED algorithm40 that predicts transmembrane
domains (TMs), predicted a protein having six TMs and a pore region between
TM5 and TM6, similar to those predicted for other TRP subtypes (Fig. 1B). The
predicted protein sequence of hTRP7, when aligned with other members of TRP
families, revealed that hTRP7 shares 98% overall identity with the mouse TRP7
protein, and 81% and 75% overall identity with hTRP3 and hTRP6 respectively.
With regard to Drosophila, the most closely related TRP channel is TRPγ, with
which hTRP7 shares 41% overall identity. The overall identity with both TRP and
TRPL is about 38%. Taken together with the lack of an hydrophobic N-terminal
signal sequence, this suggests that hTRP7 is a membrane protein with a core of
11
six transmembrane segments and a pore region, with intracellular flanking N- and
C-terminal domains41;42. Fig. 1C depicts a dendrogram of short TRP channels,
constructed using the CLUSTAL W program43. It is clear that hTRP7 is a member
of the short transient receptor potential channel family and falls into the TRP3/6/7
subfamily of short TRP channels.
The genomic structure of the hTRP7 gene was determined by comparison of the
cDNA sequence with the genomic sequences (AC008661, AC026299 and
AC063980; Table 1). hTRP7 gene appears to consist of 12 exons, although exon 6
is inferred from comparison with the genomic structures of TRP3 and TRP630 and
exon 1 is inferred from an alignment of the longer public mouse TRP7 sequence
(AF139923) to the human genomic sequence (AC063980). The genomic
sequences of human TRP7 contain a number of STS markers which have been
mapped to the chromosomal region 5q31 (Ensembl ContigView and NCBI Map
Viewer). One of these markers is the microsatellite marker locus D5S393.
BLAST searching with the nucleotide sequence of D5S393 (Z16468) against the
genomic sequence AC063980, indicates that it is situated ~300 bp upstream of the
region predicted to be exon 1 of hTRP7. Thus, D5S393 provides a useful genetic
marker for screening hTRP7 as a candidate gene for genetic diseases mapping to
this chromosomal region.
Analysis of hTRP7 mRNA Expression in Human Tissues and Cell Lines
An extensive study of mRNA distribution was carried out in human CNS regions,
peripheral tissues and a panel of cell lines using the TaqMan real-time RT-PCR
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technique36;38;39. These studies indicate that hTRP7 is widely expressed in the
CNS with the highest levels present in the nucleus accumbens and somewhat
lower expression in the putamen, striatum, hypothalamus, caudate nucleus, locus
coeruleus and medulla oblongata. Lower levels of mRNA expression were
observed in all other CNS regions studied (Fig. 2A). In peripheral tissues a high
level of hTRP7 expression was detected in pituitary gland and kidney, with lower
levels found in intestine, prostate and cartilage (Fig. 2A).
In order to identify which cell line would be most suitable for over-expression of
hTRP7, we analysed the expression of hTRP7 mRNA in a panel of cell lines. The
highest level of expression was detected in the monkey kidney fibroblast cell lines
COS-1 and COS-7, with lower expression in human kidney HK-2 cells (Fig. 2B).
No mRNA expression was detected in the other cell lines examined, including
HEK-293 cells.
Expression and localization of hTRP7 in HEK-293 cells
To perform a functional characterisation of hTRP7, a HEK-293 cell-derived
stable line was generated expressing an N-terminus FLAG-tagged hTRP7 cDNA.
Since HEK-293 cells lack detectable mRNA expression of endogenous hTRP7
(Fig 2B), they are ideal for studying the functional properties of this protein27;44.
TaqMan real time RT-PCR performed on HEK-293 clones expressing hTRP7
showed high levels of hTRP7 mRNA expression (data not shown).
The cellular localisation of the FLAG-tagged hTRP7 protein was examined with
standard immunofluorescence techniques. Fig. 2C shows a confocal image of
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cells stably transfected with hTRP7 and exposed to an anti-FLAG antibody.
Consistent with the data obtained from TaqMan analysis, considerable immuno-
reactivity was detected in the stable cell line. Comparison of cells fixed and
stained in the presence or absence of a permeabilising detergent revealed that a
fluorescent signal was detected only in  permeabilised cells, consistent with the
predicted intracellular location of the FLAG-tagged N-terminus of hTRP7 26;45
(Fig. 2C). The fluorescence was mainly associated with the plasma membrane and
sub-plasma membrane region of the transfected cells, consistent with hTRP7
being an integral membrane protein.
Functional characterisation of hTRP7
To investigate the functional role of hTRP7, carbachol (CCh) was used to activate
the phospholipase C pathway in the hTRP7 cell line via stimulation of the
endogenous muscarinic acetylcholine receptor46. We compared CCh-stimulated
[Ca2+]i changes in cells placed either in Ca2+-free medium or in medium
containing 2.0 mM CaCl2. The 340/380 nm fluorescence ratio was used to
represent changes in cytosolic [Ca2+] ([Ca2+]i). As shown in Fig. 3A, the basal
level of [Ca2+]i in Fura-2 loaded control HEK293 cells was similar in either
Ca2+-free or Ca2+-containing medium. Addition of 50 µM CCh produced a
transient elevation of [Ca2+]i which, when Ca2+ was present in the medium, fell
to a slowly declining plateau level which remained above baseline 5 minutes after
the response onset. In contrast, in Ca2+-free medium [Ca2+]i returned to baseline
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within 3 minutes. In HEK-293 cells expressing hTRP7, the basal level of Ca2+
was similar to that observed in control cells. With 2.0 mM CaCl2 present in the
medium, CCh induced a transient elevation of [Ca2+]i followed by decay to a
sustained plateau level (Fig. 3B). This increase in [Ca2+]i was approximately two
times that observed in untransfected cells. In the absence of extracellular Ca2+ the
transient elevation of [Ca2+]i in response to carbachol was very similar to that
evoked in untransfected cells.
To discriminate between CCh-induced Ca2+ release and CCh-induced Ca2+
entry, we used a standard Ca2+ depletion/ Ca2+ re-addition protocol. The cells
were incubated in Ca2+-free medium before depleting the intracellular Ca2+
stores with 50 µM CCh. Once the [Ca2+]i had returned to the basal level (4 min
after the addition of CCh), 2.0 mM CaCl2 was restored to the extracellular media.
In the absence of Ca2+, the CCh-induced Ca2+ release was similar in control and
hTRP7-transfected cells (Fig. 3C). Upon addition of 2.0 mM CaCl2 to control
cells, the [Ca2+]i increased slowly to a peak level that was less than the
magnitude of the transient peak on store release.  In contrast, in hTRP7-
transfected cells, the [Ca2+]i increased more rapidly to a level greater than that
activated by store release, before decreasing to superimpose on the declining
phase of the response in control cells. Thus, the hTRP7 expressing cells express
an additional component of Ca2+ influx on readmission of Ca2+ to the bathing
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medium following activation of a Gq-coupled, phospholipase C stimulating,
pathway.
Effect of thapsigargin on Ca2+ entry in the stable HEK-293 cells
We next used thapsigargin (TG), an inhibitor of sarcoplasmic-endoplasmic
reticulum Ca2+ pumps7, to investigate Ca2+ entry induced by passive store
depletion, in the absence of  stimulation of the receptor Gq - phospolipase C - IP3
signalling system47. In Ca2+ free medium, TG induced a rapid release of Ca2+
from intracellular stores in both control and transfected cells, as demonstrated by
the first transient increase in [Ca2+]i (Fig. 4A). There was no significant
difference in this initial increase between control and hTRP7-expressing cells.
When Ca2+ was reapplied to the cells, a second increase in [Ca2+]i was obtained,
representing the Ca2+ influx component. The peak of this increase was about 3.5-
fold higher in transfected cells than in control cells (p<0.01) (Fig. 4A). This
increase was transient in both types of cells and decreased to a sustained level that
was consistently higher in the hTRP7 transfected cells. Addition of 2.0 mM Ca2+
to cells incubated in Ca2+-free medium without TG treatment induced a similar
increase in fluorescence in both sets of cells (Fig. 4B). These data demonstrate
that, when compared to control cells, cells expressing hTRP7 display a
significantly higher level of SOC activity, but similar thapsigargin-stimulated
internal Ca2+ release and similar basal Ca2+ influx (Fig. 4B). The SOC
component (i.e. the difference between the peak [Ca2+]i increase obtained upon
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re-addition of 2.0 mM Ca2+ in untreated cells and that obtained in thapsigargin-
treated cells) in transfected cells was about 5-fold higher than in control cells.
These data demonstrate an association between hTRP7 and SOC activity, and
show that hTRP7 is responsible for enhancement of CCE through a receptor-
independent store depletion-induced pathway.
Effect of Mn2+ in hTRP7-transfected cells
Mn2+ a quencher of Fura-2 fluorescence48can enter cells through certain types of
Ca2+ influx channels49. This property can thus be used to directly monitor cation
influx through such channels. In the presence of 1 mM Mn2+, basal Mn2+ influx
in hTRP7-transfected cells was faster than in control cells (Fig. 5A). Mn2+ entry
was also determined during CCh-stimulated Ca2+ entry by adding 1mM Mn2+ 30
sec before depletion of the intracellular Ca2+ stores with CCh (Fig. 5B). CCh
stimulation increased Mn2+ entry in both control and hTRP7 expressing cells,
however a higher rate of entry was in the hTRP7  cells. Therefore, hTRP7
expression increases resting Mn2+ entry, suggesting that these channels may
exhibit a degree of constitutive activity.
Effect of Ca2+ channel blockers in hTRP7-transfected cells
In addition we investigated the ability of the lanthanide ions gadolinium (Gd3+)
and lanthanum (La3+), which are both non-specific Ca2+ channel blockers, as
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well as SKF-96365, a blocker of CCE, to inhibit Ca2+ entry using the Ca2+
depletion/ Ca2+ re-addition protocol42;50;51. Intracellular Ca2+ stores were
depleted by TG in the absence of external Ca2+ and in presence of either 250 µM
Gd3+, 250 µM La3+ or 25 µM SKF-96365. The initial [Ca2+]i increase in
response to TG was unaffected by these compounds. However, Ca2+ entry
following Ca2+ addition in control and hTRP7 transfected cells was completely
blocked by both Gd3+ and La3+ (Fig. 6A-B) Furthermore, SKF-96365
completely blocked Ca2+ entry in control cells, and caused a 94% reduction in
Ca2+ entry in hTRP7-transfected cells (Fig. 6C). These data indicate that hTRP7
may be directly involved in mediating Ca2+ entry and might be a useful tool in
identifying the type of Ca2+-influx channel present45.
Expression of anti-sense hTRP7 cDNA in cells expressing hTRP7 decreases the
SOC activity
To provide further evidence that hTRP7 was involved in a SOC entry mechanism,
the hTRP7 stable cell line was transiently transfected with hTRP7 cDNA in the
anti-sense orientation26;29;44;45. Confirmation that transient transfection of the anti-
sense construct reduced the level of hTRP7 mRNA expression was obtained by
TaqMan PCR analysis (data not shown). Functional analysis of the construct was
possible as the hTRP7 anti-sense cDNA was placed downstream of a gene
encoding a red fluorescent protein (RFP). This enabled simple identification of
the successfully transfected cell, through the fluorescent output of RFP which has
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an emmission wavelength far removed from the emission wavelength of Fura-2
which was used to monitor [Ca2+]i (Fig. 7A). To determine the effect of the
hTRP7 anti-sense construct the level of Ca2+ entry was compared between cells
expressing and lacking RFP  fluorescence. Thapsigargin stimulated internal Ca2+
release was not altered in cells transfected with the anti-sense construct (Fig. 7B).
However, the thapsigargin stimulated Ca2+ influx (second peak of [Ca2+]i
increase) was significantly reduced compared with that observed in hTRP7 cells
not expressing the anti-sense construct, and was similar to that obtained in HEK-
293. (Fig. 7B). Therefore, transient expression of hTRP7 anti-sense cDNA in the
hTRP7 cell line decreases the expression of hTRP7 mRNA and reduces the
functional activation of SOC entry by thapsigargin.
Discussion
In this report, we describe the cloning of a novel human short TRP channel,
hTRP7, that shows a high sequence identity to mouse TRP731, and substantial
homology to human TRP352 and TRP630. Sequence analysis of hTRP7 revealed
an amino acid change from the GenBank sequence, with a proline replacing a
leucine at position 111, that was not a result of a cloning artefact. This residue is
located in a region highly conserved among the short TRP family proteins and is
C-terminal to the second predicted ankyrin domain. It has been hypothesised that
TRP interactions with the cytoskeleton may be mediated through one or more of
these ~33-amino acid ankyrin repeats19 and that alteration or stabilisation of such
interactions may regulate the function of a variety of ion channels53-56. It is
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possible that the presence of a Pro instead of a Leu in this position may affect the
structure of the hTRP7 N-terminal region and influence both the interaction of the
channel with the cytoskeleton and the function of the channel itself53;55;57-60.
Future studies using mutagenesis, functional analysis and yeast two hybrid
screening, will help to address the importance of this amino acid substitution.
mRNA distribution analysis of hTRP7 demonstrated another important difference
between the human and mouse orthologues of this channel. hTRP7 was widely
expressed in tissues of the CNS, with a more restricted pattern of expression in
peripheral tissues. In contrast, the mouse homologue appears poorly expressed in
the CNS at the mRNA level, with only low levels of expression detected in the
hind brain (predominantly Purkinje cells of the cerebellum)31. Peripheral
expression of mTRP7 is also different from that of hTRP7, with highest levels of
mRNA observed in heart and lung but with little or no expression in the kidney31.
These differences suggest that mouse and human TRP7 channels may have quite
distinct physiological roles despite their high sequence homology.
Functionally hTRP7 was also demonstrated to behave quite differently to mTRP7.
Following agonist (CCh) stimulation in the absence of Ca2+, Ca2+ entry into
hTRP7 transfected cells was markedly increased compared to control cells
following re-addition of extracellular Ca2+. Furthermore, hTRP7 expressing cells
displayed significantly increased thapsigargin stimulated Ca2+ influx compared to
control cells. This increased capacitative entry was abolished by transfection with
an anti-sense hTRP7 expression construct. This data suggests following emptying
of intracellular Ca2+ stores, hTRP7 channel has a role in both receptor dependent
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CCE elicited by the agonist driven Gq-coupled phospholipase C pathway, as well
by a receptor independent store depletion induced pathway21. This is in clear
contrast to the functional role previously described for mTRP7, which when
expressed in a similar HEK-293 cell line, demonstrated receptor-activated
behaviour independent of Ca2+ store depletion31.
Despite the 98% protein identity between the two channels, sequence alignment
of human and mouse TRP7 reveals differences that could potentially affect
channel function. In particular, amino acid differences located in the C-terminal
region could affect the interaction of the channels with components of signal
transduction machinery such as calmodulin, Na+/H+ exchanger regulatory factor
(NHRF) and inositol 1,4,5 triphosphate receptors61-63. Studies with chimeric
channels and mutagenesis experiments may help to clarify the role that these
domains play in channel function.
It is important to note that these channels do not function in isolation. Thus the
activity of a recombinantly expressed protein may also be influenced by the
endogenous TRP channels as well as associated regulatory mechanisms present in
the cells in which these channels are expressed. It has previously been reported
that TRP channels can form both homomeric or heteromeric complexes, with
either TRP proteins or other unidentified proteins. For example, interactions have
been reported for hTRP1 with both hTRP364 and hTRP565. In addition,
heteromultimers have been reported between Drosophila TRP and TRPL46, and
TRPL and TRPγ11. Such protein-protein interactions could certainly influence the
characteristics and regulation of TRP channel activity in various cells. Clearly,
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further studies are required for a more complete understanding of TRP channel
function and an important aspect of these studies will be to determine the
presence and co-localisation of the short TRP proteins in different tissues and cell
types.
In conclusion, we have identified hTRP7, the human orthologue of mTRP731.
This channel appears to be functionally distinct from its rodent counterpart in
terms of its distribution profile and its role in receptor-independent SOC entry.
These studies highlight the importance of investigating species orthologues and
suggest that hTRP7 should be considered as functionally distinct to its closest
relatives TRP3 and TRP6.
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Figure Legends
Fig. 1. Sequence comparisons of human TRP7. A. Predicted human TRP7
(hTRP7) protein sequence aligned with mouse TRP7 (mTRP7). Identitical
residues are shown as dots. Pro111 is highlighted with an arrow. Three potential
ankyrin repeat domains, detected by SMART, are indicated by dotted lines.
Hydrophobic regions representing TM domains 1-6 are shown by lines (S1 to S6)
and the predicted pore loop region is indicated by a dashed line (pore). Consensus
sites for phosphorylation are highlighted - those for protein kinase A (filled
diamond) and protein kinase C (filled circles). A single potential N-glycosylation
site is marked by an asterisk. Amino acids are numbered on the right. B. The
prediction graphics of membrane spanning regions from TMPRED. S1-S6 denote
putative transmembrane segments and a putative pore loop is indicated as P. C.
Unrooted dendogram showing the evolutionary relationship among all currently
known mammalian short TRP channels. The scale bar is a function of amino acid
substitution scores based on the BLOSUM series protein weight matrix.
Fig. 2. TaqMan RT-PCR analysis of hTRP7 in human tissues and cell lines.
A. cDNA from the reverse transcription of 1 ng poly(A)+ RNA from multiple
tissues of four non-diseased individuals was assessed for hTRP7 mRNA. Data are
presented as a mean ± S.E.M. (pmbc, peripheral blood mononuclear cells, drg,
dorsal root ganglion). B. Distribution profile in a panel of cell lines. Data are
presented as arbitrary fluorescent units and are normalised to the housekeeping
gene β-actin. C. (i) Localisation of hTRP7 protein in a HEK-293 cell line
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expressing Flag-tagged hTRP7 mRNA (HEK-293 hTRP7 cells). Fluorescence
was detected predominantly in the plasma membrane region of all cells. (ii)
Immunofluorescence analysis with the anti-Flag antibody on untransfected HEK-
293 cells.
Fig. 3. Development of CCE in control and HEK-293 cells transfected with
hTRP7. [Ca2+]i transients were determined by Fura-2 radiometric fluorescence
spectroscopy. A. Changes in [Ca2+]i upon CCh stimulation in the absence of
external Ca2+ (open circles) or in the presence of 2 mM external Ca2+ (filled
circles) in HEK-293 cells. B. Same as in A but using HEK-293 hTRP7 cells. C.
[Ca2+]i increase upon CCh stimulation in the absence of external Ca2+ followed by
CCh-induced Ca2+ entry after re-addition of external Ca2+ in HEK-293 cells (open
circles) or HEK-293 hTRP7 cells (filled circles). This [Ca2+]i increase in hTRP7
cells was 2.6 times that observed in untrasfected cells. Results are mean ± S.E.M
of [Ca2+]i from the indicated number of the cells.
Fig. 4. Thapsigargin-stimulated Ca2+ entry in control and hTRP7 transfected
HEK-293 cells. A Changes in [Ca2+]i upon TG stimulation in the absence of
external Ca2+ or in presence of 2.0 mM external Ca2+ in HEK-293 cells (open
circles) or HEK-293 hTRP7 cells (filled circles). B. Average of the peak [Ca2+]i
increases due to Ca2+ influx under basal or TG treated conditions. The SOC
component in transfected cells was about 5-fold higher than in control cells.
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Fig. 5. Influx of Mn2+ into control and hTRP7 transfected cells. A.
Fluorescence quenching due to Mn2+ influx was observed in Fura-2 loaded
control and HEK-293 hTRP7 cells. Mn2+ (1mM) was added to nominally Ca2+-
free medium. B. 50 µM CCh was added to the cells 30 sec after the addition of
Mn2+. In CCh-stimulated cells the quenching effect was increased in both control
and the hTRP7 cells.
Fig. 6. Effect of lanthanides and SKF-96365 on Ca2+ influx in control and
hTRP7 transfected cells. A-B. TG induced Ca2+ entry in Fura-2 loaded HEK-
293 (open circles) and HEK-293 hTRP7 cells (filled circles) was completely
blocked by both 250 µM Gd3+ and 250 µM La3+. C. 25 µM SKF-96365 also
blocked Ca2+ entry in  and HEK-293 hTRP7 cells. Results are mean ± S.E.M of
[Ca2+]i from the indicated number of the cells.
Fig. 7. Transient transfection of an hTRP7 cell line with pAsRed1-C1-
hTRP7AS construct. A. HEK-293 hTRP7 cells expressing red fluorescent protein
(RFP) following transient transfection with the pAsRed1-C1-hTRP7AS construct.
B. Peak of [Ca2+]i (340/380 ratio), measured upon addition of TG in Ca2+ free
medium and after re-addition of 2 mM Ca2+ to the HEK-293 hTRP7 cell line,
transiently transfected with  pAsRed1-C1-hTRP7AS. Thapsigargin stimulated Ca2+
influx was significantly reduced in cells expressing pAsRed1-C1-hTRP7AS
compared to non-fluorescent cells expressing only hTRP7.
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Table 1. Predicted exon-intron boundaries of hTRP7. The genomic structure
of hTRP7 gene, was determined by comparison of the cDNA sequence reported in
this manuscript (AJ421783) to genomic sequences AC008661, AC026299 and
AC063980. Exonic and intronic sequences are shown in upper and lowercase
respectively. All intron boundaries obey the gt-ag rule. aExon 1 is implicated
from mTRP7 (AF139923). bExon 6 splice acceptor and donor sites are not yet
available in genomic DNA.
Exon
number
Exon length
(bp)
Position of
Exon on
cDNA
Boundaries
5' -  intron EXON…EXON intron - 3'
a1 >2 1-2 ...CCTCAAT/gtaagca
2 778 3-780 cccatag/GTTGAGG...ATTTAAG/gtaactc
3 183 781-963 ctgttag/AACGATT...CAAGAAG/gtaagct
4 165 964-1128 tttacag/TTCGTTG...CAGCAAG/gtacaga
5 217 1129-1345 tttccag/CTAGGAC...GTCTTAG/gtaagca
6 234 1346-1579 bNA
7 265 1580-1844 cttttag/CCAGGGA...TTACAAC/gtgagta
8 196 1845-2040 tttgcag/GGTTGAA...AATTGAG/gtaaggc
9 222 2041-2262 tccacag/GAGGATG...ATTCAAG/gtaggta
10 81 2263-2343 tatccag/AAGACTC...ATACCAG/gtaacca
11 76 2344-2419 atttcag/AAAATCA...AATGAAG/gtaaatg
12 170 2420-2589 cttgcag/GCGAGCT...
rTRP3mTRP3
hTRP3
0.1
bTRP4hTRP4
rTRP4
mTRP4
rbTRP5 hTRP5
mTRP5
hTRP1 rbTRP1
rTRP1
bTRP1
rTRP2
mTRP2
hTRP6
 gpTRP6
rTRP6
mTRP6
hTRP7
mTRP7
mTRP1
Fig. 1
A
C
• ♦ •
hTRP7 MLRNSTFKNMQRRHTTLREKGRRQAIRGPAYMFNEKGTSLTPEEERFLDSAEYGNIPVVRKMLEESKTLNFNCVDYMGQN 80
mTRP7 ..GSN...........................................................................
hTTP7 ALQLAVGNEHLEVTELLLKKENLARVGDALPLAISKGYVRIVEAILNHPAFAQGQRLTLSPLEQELRDDDFYAYDEDGTR 160
mTRP7 ..............................L...............S.................................
• ♦
hTRP7 FSHDITPIILAAHCQEYEIVHILLLKGARIERPHDYFCKCNECTEKQRKDSFSHSRSRMNAYKGLASAAYLSLSSEDPVL 240
mTRP7 ................................................................................
♦
hTRP7 TALELSNELARLANIETEFKNDYRKLSMQCKDFVVGVLDLCRDTEEVEAILNGDVNFQVWSDHHRPSLSRIKLAIKYEVK 320
mTRP7 ........................................................L.......................
hTRP7 KFVAHPNCQQQLLTMWYENLSGLRQQSIAVKFLAVFGVSIGLPFLAIAYWIAPCSKLGRTLRSPFMKFVAHAVSFTIFLG 400
mTRP7 ..........................................................Q.....................
•
hTRP7 LLVVNASDRFEGVKTLPNETFTDYPKQIFRVKTTQFSWTEMLIMKWVLGMIWSECKEIWEEGPREYVLHLWNLLDFGMLS 480
mTRP7 ................................................................................
∗
hTRP7 IFVASFTARFMAFLKATEAQLYVDQHVQDDTLHNVSLPPEVAYFTYARDKWWPSDPQIISEGLYAIAVVLSFSRIAYILP 560
mTRP7 ................S........Y...V..................................................
•
hTRP7 ANESFGPLQISLGRTVKDIFKFMVIFIMVFVAFMIGMFNLYSYYRGAKYNPAFTTVEESFKTLFWSIFGLSEVISVVLKY 640
mTRP7 ................................................................................
•
hTRP7 DHKFIENIGYVLYGVYNVTMVVVLLNMLIAMINNSYQEIEEDADVEWKFARAKLWLSYFDEGRTLPAPFNLVPSPKSFYY 720
mTRP7 ................................................................................
hTRP7 LIMRIKMCLIKLCKSKAKSCENDLEMGMLNSKFKKTRYQAGMRNSENLTANNTLSKPTRYQKIMKRLIKRYVLKAQVDRE 800
mTRP7 ..........E..Q....R..............R.................S.F..........................
• •
hTRP7 NDEVNEGELKEIKQDISSLRYELLEEKSQATGELADLIQQLSEKFGKNLNKDHLRVNKGKDI 862
mTRP7 .........................................................Q....
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